Nordea Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-702,181
Closed -$7.79M 957
2022
Q4
$7.79M Buy
702,181
+574,381
+449% +$8.51M 0.01% 426
2022
Q3
$2.22M Hold
127,800
﹤0.01% 660
2022
Q2
$2.72M Sell
127,800
-17,101
-12% -$474K ﹤0.01% 656
2022
Q1
$5.53M Buy
144,901
+1,980
+1% +$77.2K 0.01% 563
2021
Q4
$6.65M Sell
142,921
-2,333
-2% -$122K 0.01% 524
2021
Q3
$9.01M Buy
145,254
+1,628
+1% +$124K 0.01% 433
2021
Q2
$13.1M Buy
143,626
+8,109
+6% +$645K 0.02% 353
2021
Q1
$9.08M Sell
135,517
-3,370
-2% -$262K 0.01% 392
2020
Q4
$10.1M Sell
138,887
-2,723
-2% -$158K 0.02% 360
2020
Q3
$5.33M Sell
141,610
-138,890
-50% -$4.69M 0.01% 442
2020
Q2
$9.55M Buy
+280,500
New +$7.98M 0.01% 457

Other funds holding CDNA

Nordea Investment Management's CDNA Position: Q1 2023 in Review

Nordea Investment Management sold out of CareDx (CDNA) in Q1 2023, closing a stake of 702,181 shares — an estimated $7.79M sold.

Nordea Investment Management first reported a position in CDNA in Q2 2020 and held it in 11 quarters. The position peaked at $13.1M in Q2 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Nordea Investment Management reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Nordea Investment Management sold 702,181 CareDx shares in Q1 2023, an estimated $7.79M.
  • Nordea Investment Management first reported a position in CareDx in Q2 2020 and held it in 11 quarters.
  • Nordea Investment Management's CareDx position peaked at $13.1M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Nordea Investment Management's 13F filing for Q1 2023, filed 19 Apr 2023.